BIA submission to the European Commission in response to the consultation on the evaluation of the European Medicines Agency fee system

Influencing and shaping our sector, BIA update: April - July 2018

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from April to July 2018.

Brexit White Paper – The Future Relationship between UK and the EU

We now have more detail and clarity for the sector following the publication by Government of their Brexit White Paper, which you can read in full here The Paper builds on previous Government communications and provides more public confirmation that UK Government would like the UK to retain regulatory cooperation on medicines with the EU as part of the desired future relationship. 

Guide to the Government for BIA members

This is a briefing for BIA members on the new Government and key ministerial appointments for our sector.